1. Metallo-β-lactamase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence type 
A.K. Van der Bij, D. Van der Zwan, G. Peirano, J.A. Severin, J.D.D. Pitout, M. Van Westreenen, W.H.F. Goessens 
Clinical Microbiology and Infection 
Volume 18, Issue 9, Pages E369-E372 (September 2012)
DOI: /j x
Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

2. FIG. 1.
Resistance % for 206 carbapenem non-susceptible Pseudomonas aeruginosa isolates isolated from various care facilities in the Netherlands, from November 2009 to May IMP, imipenem; MEM, meropenem; PIP, piperacillin; CAZ, ceftazidime; TOB, tobramycin; AMK, amikacin; CIP, ciprofloxacin; AZT, aztreonam; COL, colistin.
Clinical Microbiology and Infection  , E369-E372DOI: ( /j x)
Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

3. FIG. 2.
MLVA genotyping of MBL-producing P. aeruginosa isolates of 82 patients from various care facilities in the Netherlands, from November 2009 to May 2011, shows one large cluster of 70 patients, a smaller cluster of 11 patients (no. 68 and 409), and a single strain unrelated to any of the three clusters (no. 384).
Clinical Microbiology and Infection  , E369-E372DOI: ( /j x)
Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions